Predicting meningioma grades and pathologic marker expression via deep learning

Eur Radiol. 2024 May;34(5):2997-3008. doi: 10.1007/s00330-023-10258-2. Epub 2023 Oct 19.

Abstract

Objectives: To establish a deep learning (DL) model for predicting tumor grades and expression of pathologic markers of meningioma.

Methods: A total of 1192 meningioma patients from two centers who underwent surgical resection between September 2018 and December 2021 were retrospectively included. The pathological data and post-contrast T1-weight images for each patient were collected. The patients from institute I were subdivided into training, validation, and testing sets, while the patients from institute II served as the external testing cohort. The fine-tuned ResNet50 model based on transfer learning was adopted to classify WHO grade in the whole cohort and predict Ki-67 index, H3K27me3, and progesterone receptor (PR) status of grade 1 meningiomas. The predictive performance was evaluated by the accuracy and loss curve, confusion matrix, receiver operating characteristic curve (ROC), and area under curve (AUC).

Results: The DL prediction model for each label achieved high predictive performance in two cohorts. For WHO grade prediction, the area under the curve (AUC) was 0.966 (95%CI 0.957-0.975) in the internal testing set and 0.669 (95%CI 0.643-0.695) in the external validation cohort. The AUC in predicting Ki-67 index, H3K27me3, and PR status were 0.905 (95%CI 0.895-0.915), 0.773 (95%CI 0.760-0.786), and 0.771 (95%CI 0.750-0.792) in the internal testing set and 0.591 (95%CI 0.562-0.620), 0.658 (95%CI 0.648-0.668), and 0.703 (95%CI 0.674-0.732) in the external validation cohort, respectively.

Conclusion: DL models can preoperatively predict meningioma grades and pathologic marker expression with favorable predictive performance.

Clinical relevance statement: Our DL model could predict meningioma grades and expression of pathologic markers and identify high-risk patients with WHO grade 1 meningioma, which would suggest a more aggressive operative intervention preoperatively and a more frequent follow-up schedule postoperatively.

Key points: WHO grades and some pathologic markers of meningioma were associated with therapeutic strategies and clinical outcomes. A deep learning-based approach was employed to develop a model for predicting meningioma grades and the expression of pathologic markers. Preoperative prediction of meningioma grades and the expression of pathologic markers was beneficial for clinical decision-making.

Keywords: Deep learning; Magnetic resonance imaging; Meningioma; Radiomics.

Publication types

  • Multicenter Study

MeSH terms

  • Adult
  • Aged
  • Biomarkers, Tumor* / metabolism
  • Deep Learning*
  • Female
  • Humans
  • Ki-67 Antigen / metabolism
  • Magnetic Resonance Imaging / methods
  • Male
  • Meningeal Neoplasms* / diagnostic imaging
  • Meningeal Neoplasms* / metabolism
  • Meningeal Neoplasms* / pathology
  • Meningioma* / diagnostic imaging
  • Meningioma* / metabolism
  • Meningioma* / pathology
  • Middle Aged
  • Neoplasm Grading*
  • Predictive Value of Tests
  • Retrospective Studies

Substances

  • Biomarkers, Tumor
  • Ki-67 Antigen